| Gene information | Literature | Expression | lncRNA | Mutation | Homolog |
Basic Information | |
|---|---|
Gene ID | 5290 |
Name | PIK3CA |
Synonym | CLOVE|CWS5|MCAP|MCM|MCMTC|PI3K|p110-alpha;phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha;PIK3CA;phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha |
Definition | PI3-kinase p110 subunit alpha|PI3K-alpha|phosphatidylinositol 3-kinase, catalytic, 110-KD, alpha|phosphatidylinositol 3-kinase, catalytic, alpha polypeptide|phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform|phosphatidylinosito |
Position | 3q26.3 |
Gene Type | protein-coding |
Pathways and Diseases | |
Pathway | il-2 receptor beta chain in t cell activation;PID BioCarta;100129 |
Pathway | Fc gamma R-mediated phagocytosis;KEGG PATHWAY;hsa04666 |
Pathway | Axon guidance mediated by netrin;PANTHER;P00009 |
Pathway | Phosphatidylinositol signaling system;KEGG PATHWAY;hsa04070 |
Pathway | role of erbb2 in signal transduction and oncology;PID BioCarta;100147 |
Pathway | Signaling by Insulin receptor;Reactome;REACT:498 |
Pathway | role of pi3k subunit p85 in regulation of actin organization and cell migration;PID BioCarta;100211 |
Pathway | phospholipase c signaling pathway;PID BioCarta;100069 |
Pathway | Endometrial cancer;KEGG PATHWAY;hsa05213 |
Pathway | insulin signaling pathway;PID BioCarta;100124 |
Pathway | mtor signaling pathway;PID BioCarta;100101 |
Pathway | pdgf signaling pathway;PID BioCarta;100077 |
Pathway | FGF signaling pathway;PANTHER;P00021 |
Pathway | Bacterial invasion of epithelial cells;KEGG PATHWAY;hsa05100 |
Pathway | Amoebiasis;KEGG PATHWAY;hsa05146 |
Pathway | pten dependent cell cycle arrest and apoptosis;PID BioCarta;100058 |
Pathway | Neurotrophin signaling pathway;KEGG PATHWAY;hsa04722 |
Pathway | PDGF signaling pathway;PANTHER;P00047 |
Pathway | egf signaling pathway;PID BioCarta;100181 |
Pathway | EGF receptor signaling pathway;PANTHER;P00018 |
Pathway | Signaling by GPCR;Reactome;REACT:14797 |
Pathway | Aldosterone-regulated sodium reabsorption;KEGG PATHWAY;hsa04960 |
Pathway | inhibition of cellular proliferation by gleevec;PID BioCarta;100154 |
Pathway | EPHA2 forward signaling;PID Curated;200185 |
Pathway | Progesterone-mediated oocyte maturation;KEGG PATHWAY;hsa04914 |
Pathway | Inositol phosphate metabolism;KEGG PATHWAY;hsa00562 |
Pathway | the igf-1 receptor and longevity;PID BioCarta;100115 |
Pathway | IL1-mediated signaling events;PID Curated;200075 |
Pathway | nfat and hypertrophy of the heart ;PID BioCarta;100098 |
Pathway | b cell survival pathway;PID BioCarta;100228 |
Pathway | Toll-like receptor signaling pathway;KEGG PATHWAY;hsa04620 |
Pathway | tpo signaling pathway;PID BioCarta;100012 |
Pathway | regulation of bad phosphorylation;PID BioCarta;100233 |
Pathway | Apoptosis signaling pathway;PANTHER;P00006 |
Pathway | IL2 signaling events mediated by PI3K;PID Curated;200099 |
Pathway | p53 pathway feedback loops 2;PANTHER;P04398 |
Pathway | trka receptor signaling pathway;PID BioCarta;100011 |
Pathway | Atypical NF-kappaB pathway;PID Curated;200017 |
Pathway | multiple antiapoptotic pathways from igf-1r signaling lead to bad phosphorylation;PID BioCarta;100135 |
Pathway | VEGFR1 specific signals;PID Curated;200151 |
Pathway | Signaling events mediated by VEGFR1 and VEGFR2;PID Curated;200161 |
Pathway | Toxoplasmosis;KEGG PATHWAY;hsa05145 |
Pathway | BCR signaling pathway;PID Curated;200005 |
Pathway | Signaling by PDGF;Reactome;REACT:16888 |
Pathway | human cytomegalovirus and map kinase pathways;PID BioCarta;100149 |
Pathway | 3-phosphoinositide biosynthesis;BioCyc;PWY-6352 |
Pathway | growth hormone signaling pathway;PID BioCarta;100155 |
Pathway | IL2-mediated signaling events;PID Curated;200082 |
Pathway | nerve growth factor pathway (ngf);PID BioCarta;100096 |
Pathway | Colorectal cancer;KEGG PATHWAY;hsa05210 |
Pathway | p53 pathway;PANTHER;P00059 |
Pathway | B cell activation;PANTHER;P00010 |
Pathway | Prostate cancer;KEGG PATHWAY;hsa05215 |
Pathway | Insulin/IGF pathway-protein kinase B signaling cascade;PANTHER;P00033 |
Pathway | Angiogenesis;PANTHER;P00005 |
Pathway | phospholipids as signalling intermediaries;PID BioCarta;100183 |
Pathway | Pathways in cancer;KEGG PATHWAY;hsa05200 |
Pathway | transcription factor creb and its extracellular signals;PID BioCarta;100198 |
Pathway | inactivation of gsk3 by akt causes accumulation of b-catenin in alveolar macrophages;PID BioCarta;100152 |
Pathway | Melanoma;KEGG PATHWAY;hsa05218 |
Pathway | Glioma;KEGG PATHWAY;hsa05214 |
Pathway | Gab1 signalosome;PID Reactome;500514 |
Pathway | role of nicotinic acetylcholine receptors in the regulation of apoptosis;PID BioCarta;100255 |
Pathway | Interleukin signaling pathway;PANTHER;P00036 |
Pathway | influence of ras and rho proteins on g1 to s transition;PID BioCarta;100054 |
Pathway | B cell receptor signaling pathway;KEGG PATHWAY;hsa04662 |
Pathway | ras-independent pathway in nk cell-mediated cytotoxicity;PID BioCarta;100095 |
Pathway | thrombin signaling and protease-activated receptors;PID BioCarta;100082 |
Pathway | Regulation of actin cytoskeleton;KEGG PATHWAY;hsa04810 |
Pathway | E-cadherin signaling in keratinocytes;PID Curated;200125 |
Pathway | trefoil factors initiate mucosal healing;PID BioCarta;100018 |
Pathway | p75(NTR)-mediated signaling;PID Curated;200103 |
Pathway | Pancreatic cancer;KEGG PATHWAY;hsa05212 |
Pathway | Trk receptor signaling mediated by PI3K and PLC-gamma;PID Curated;200183 |
Pathway | skeletal muscle hypertrophy is regulated via akt-mtor pathway;PID BioCarta;100137 |
Pathway | T cell receptor signaling pathway;KEGG PATHWAY;hsa04660 |
Pathway | Nongenotropic Androgen signaling;PID Curated;200145 |
Pathway | corticosteroids and cardioprotection;PID BioCarta;100156 |
Pathway | tumor suppressor arf inhibits ribosomal biogenesis;PID BioCarta;100237 |
Pathway | Signaling by EGFR;Reactome;REACT:9417 |
Pathway | Inflammation mediated by chemokine and cytokine signaling pathway;PANTHER;P00031 |
Pathway | Signalling by NGF;Reactome;REACT:11061 |
Pathway | fc epsilon receptor i signaling in mast cells;PID BioCarta;100165 |
Pathway | bioactive peptide induced signaling pathway;PID BioCarta;100226 |
Pathway | S1P2 pathway;PID Curated;200181 |
Pathway | Integrin signalling pathway;PANTHER;P00034 |
Pathway | mTOR signaling pathway;KEGG PATHWAY;hsa04150 |
Pathway | ras signaling pathway;PID BioCarta;100047 |
Pathway | Renal cell carcinoma;KEGG PATHWAY;hsa05211 |
Pathway | actions of nitric oxide in the heart;PID BioCarta;100094 |
Pathway | the co-stimulatory signal during t-cell activation;PID BioCarta;100193 |
Pathway | cxcr4 signaling pathway;PID BioCarta;100192 |
Pathway | Fc epsilon RI signaling pathway;KEGG PATHWAY;hsa04664 |
Pathway | Interactions of the immunoglobulin superfamily (IgSF) member proteins;Reactome;REACT:23853 |
Pathway | Hemostasis;Reactome;REACT:604 |
Pathway | erk and pi-3 kinase are necessary for collagen binding in corneal epithelia;PID BioCarta;100184 |
Pathway | IL23-mediated signaling events;PID Curated;200131 |
Pathway | il-7 signal transduction;PID BioCarta;100125 |
Pathway | vegf hypoxia and angiogenesis;PID BioCarta;100006 |
Pathway | a6b1 and a6b4 Integrin signaling;PID Curated;200162 |
Pathway | Natural killer cell mediated cytotoxicity;KEGG PATHWAY;hsa04650 |
Pathway | GMCSF-mediated signaling events;PID Curated;200015 |
Pathway | Signaling in Immune system;Reactome;REACT:6900 |
Pathway | Small cell lung cancer;KEGG PATHWAY;hsa05222 |
Pathway | igf-1 signaling pathway;PID BioCarta;100136 |
Pathway | Fc-epsilon receptor I signaling in mast cells;PID Curated;200003 |
Pathway | akt signaling pathway;PID BioCarta;100245 |
Pathway | VEGF signaling pathway;KEGG PATHWAY;hsa04370 |
Pathway | IL4-mediated signaling events;PID Curated;200018 |
Pathway | Focal adhesion;KEGG PATHWAY;hsa04510 |
Pathway | Chronic myeloid leukemia;KEGG PATHWAY;hsa05220 |
Pathway | Endothelin signaling pathway;PANTHER;P00019 |
Pathway | Osteopontin-mediated events;PID Curated;200042 |
Pathway | T cell activation;PANTHER;P00053 |
Pathway | Reelin signaling pathway;PID Curated;200051 |
Pathway | Neurotrophic factor-mediated Trk receptor signaling;PID Curated;200128 |
Pathway | Carbohydrate digestion and absorption;KEGG PATHWAY;hsa04973 |
Pathway | Leukocyte transendothelial migration;KEGG PATHWAY;hsa04670 |
Pathway | role of erk5 in neuronal survival pathway;PID BioCarta;100171 |
Pathway | Hepatitis C;KEGG PATHWAY;hsa05160 |
Pathway | PI3 kinase pathway;PANTHER;P00048 |
Pathway | IL6-mediated signaling events;PID Curated;200124 |
Pathway | ctcf: first multivalent nuclear factor;PID BioCarta;100194 |
Pathway | IL2 signaling events mediated by STAT5;PID Curated;200158 |
Pathway | Insulin signaling pathway;KEGG PATHWAY;hsa04910 |
Pathway | Hypoxia response via HIF activation;PANTHER;P00030 |
Pathway | VEGF signaling pathway;PANTHER;P00056 |
Pathway | ErbB signaling pathway;KEGG PATHWAY;hsa04012 |
Pathway | Plasma membrane estrogen receptor signaling;PID Curated;200029 |
Pathway | Non-small cell lung cancer;KEGG PATHWAY;hsa05223 |
Pathway | rac1 cell motility signaling pathway;PID BioCarta;100056 |
Pathway | t cell receptor signaling pathway;PID BioCarta;100022 |
Pathway | control of skeletal myogenesis by hdac and calcium/calmodulin-dependent kinase (camk);PID BioCarta;100148 |
Pathway | Chagas disease;KEGG PATHWAY;hsa05142 |
Pathway | Jak-STAT signaling pathway;KEGG PATHWAY;hsa04630 |
Pathway | Apoptosis;KEGG PATHWAY;hsa04210 |
Pathway | Chemokine signaling pathway;KEGG PATHWAY;hsa04062 |
Pathway | Signaling by FGFR;Reactome;REACT:9470 |
Pathway | Type II diabetes mellitus;KEGG PATHWAY;hsa04930 |
Pathway | Ras Pathway;PANTHER;P04393 |
Pathway | regulation of eif-4e and p70s6 kinase;PID BioCarta;100178 |
Pathway | Acute myeloid leukemia;KEGG PATHWAY;hsa05221 |
Disease | Keratosis, seborrheic, somatic;OMIM |
Disease | Cancers;KEGG DISEASE |
Disease | Nonsmall cell lung cancer, somatic;OMIM |
Disease | Ovarian cancer, somatic;OMIM |
Disease | breast cancer;GAD |
Disease | Colonic Neoplasms;GAD |
Disease | Colorectal cancer, somatic;OMIM |
Disease | Nevus, epidermal;OMIM |
Disease | CANCER;GAD |
Disease | Gastric cancer, somatic;OMIM |
Disease | Ovarian cancer;KEGG DISEASE;H00027 |
Disease | Breast cancer, somatic;OMIM |
Disease | Cancers of the breast and female genital organs;KEGG DISEASE |
Disease | Hepatocellular carcinoma, somatic;OMIM |
Disease | colorectal cancer;GAD |
External Links | |
Links to cell senescence gene database | 5290 |
Links to epithelial mesenchymal transition gene database | 5290 |
Links to ovarian cancer gene database | 5290 |
Links to endometrial cancer gene database | 5290 |
Links to iHOP | 5290 |
Sequence Information | |
Nucleotide Sequence | >5290 : length: 9109 TTCCGGGGGATTGTAGGCTCTGCCCCTCCTCAGCTCTTACCCTCTTCTGCCGGAGGAGGG GGGGGGCCGAGGGGGTGGGGAAGAGTTCGTTGTTTGTTTACACGATGTTTCTGCTTTGGG ACAACCATACATCTAATTCCTTAAAGTAGTTTTATATGTAAAACTTGCAAAGAATCAGAA CAATGCCTCCACGACCATCATCAGGTGAACTGTGGGGCATCCACTTGATGCCCCCAAGAA TCCTAGTAGAATGTTTACTACCAAATGGAATGATAGTGACTTTAGAATGCCTCCGTGAGG CTACATTAATAACCATAAAGCATGAACTATTTAAAGAAGCAAGAAAATACCCCCTCCATC AACTTCTTCAAGATGAATCTTCTTACATTTTCGTAAGTGTTACTCAAGAAGCAGAAAGGG AAGAATTTTTTGATGAAACAAGACGACTTTGTGACCTTCGGCTTTTTCAACCCTTTTTAA AAGTAATTGAACCAGTAGGCAACCGTGAAGAAAAGATCCTCAATCGAGAAATTGGTTTTG CTATCGGCATGCCAGTGTGTGAATTTGATATGGTTAAAGATCCAGAAGTACAGGACTTCC GAAGAAATATTCTGAACGTTTGTAAAGAAGCTGTGGATCTTAGGGACCTCAATTCACCTC ATAGTAGAGCAATGTATGTCTATCCTCCAAATGTAGAATCTTCACCAGAATTGCCAAAGC ACATATATAATAAATTAGATAAAGGGCAAATAATAGTGGTGATCTGGGTAATAGTTTCTC CAAATAATGACAAGCAGAAGTATACTCTGAAAATCAACCATGACTGTGTACCAGAACAAG TAATTGCTGAAGCAATCAGGAAAAAAACTCGAAGTATGTTGCTATCCTCTGAACAACTAA AACTCTGTGTTTTAGAATATCAGGGCAAGTATATTTTAAAAGTGTGTGGATGTGATGAAT ACTTCCTAGAAAAATATCCTCTGAGTCAGTATAAGTATATAAGAAGCTGTATAATGCTTG GGAGGATGCCCAATTTGATGTTGATGGCTAAAGAAAGCCTTTATTCTCAACTGCCAATGG ACTGTTTTACAATGCCATCTTATTCCAGACGCATTTCCACAGCTACACCATATATGAATG GAGAAACATCTACAAAATCCCTTTGGGTTATAAATAGTGCACTCAGAATAAAAATTCTTT GTGCAACCTACGTGAATGTAAATATTCGAGACATTGATAAGATCTATGTTCGAACAGGTA TCTACCATGGAGGAGAACCCTTATGTGACAATGTGAACACTCAAAGAGTACCTTGTTCCA ATCCCAGGTGGAATGAATGGCTGAATTATGATATATACATTCCTGATCTTCCTCGTGCTG CTCGACTTTGCCTTTCCATTTGCTCTGTTAAAGGCCGAAAGGGTGCTAAAGAGGAACACT GTCCATTGGCATGGGGAAATATAAACTTGTTTGATTACACAGACACTCTAGTATCTGGAA AAATGGCTTTGAATCTTTGGCCAGTACCTCATGGATTAGAAGATTTGCTGAACCCTATTG GTGTTACTGGATCAAATCCAAATAAAGAAACTCCATGCTTAGAGTTGGAGTTTGACTGGT TCAGCAGTGTGGTAAAGTTCCCAGATATGTCAGTGATTGAAGAGCATGCCAATTGGTCTG TATCCCGAGAAGCAGGATTTAGCTATTCCCACGCAGGACTGAGTAACAGACTAGCTAGAG ACAATGAATTAAGGGAAAATGACAAAGAACAGCTCAAAGCAATTTCTACACGAGATCCTC TCTCTGAAATCACTGAGCAGGAGAAAGATTTTCTATGGAGTCACAGACACTATTGTGTAA CTATCCCCGAAATTCTACCCAAATTGCTTCTGTCTGTTAAATGGAATTCTAGAGATGAAG TAGCCCAGATGTATTGCTTGGTAAAAGATTGGCCTCCAATCAAACCTGAACAGGCTATGG AACTTCTGGACTGTAATTACCCAGATCCTATGGTTCGAGGTTTTGCTGTTCGGTGCTTGG AAAAATATTTAACAGATGACAAACTTTCTCAGTATTTAATTCAGCTAGTACAGGTCCTAA AATATGAACAATATTTGGATAACTTGCTTGTGAGATTTTTACTGAAGAAAGCATTGACTA ATCAAAGGATTGGGCACTTTTTCTTTTGGCATTTAAAATCTGAGATGCACAATAAAACAG TTAGCCAGAGGTTTGGCCTGCTTTTGGAGTCCTATTGTCGTGCATGTGGGATGTATTTGA AGCACCTGAATAGGCAAGTCGAGGCAATGGAAAAGCTCATTAACTTAACTGACATTCTCA AACAGGAGAAGAAGGATGAAACACAAAAGGTACAGATGAAGTTTTTAGTTGAGCAAATGA GGCGACCAGATTTCATGGATGCTCTACAGGGCTTTCTGTCTCCTCTAAACCCTGCTCATC AACTAGGAAACCTCAGGCTTGAAGAGTGTCGAATTATGTCCTCTGCAAAAAGGCCACTGT GGTTGAATTGGGAGAACCCAGACATCATGTCAGAGTTACTGTTTCAGAACAATGAGATCA TCTTTAAAAATGGGGATGATTTACGGCAAGATATGCTAACACTTCAAATTATTCGTATTA TGGAAAATATCTGGCAAAATCAAGGTCTTGATCTTCGAATGTTACCTTATGGTTGTCTGT CAATCGGTGACTGTGTGGGACTTATTGAGGTGGTGCGAAATTCTCACACTATTATGCAAA TTCAGTGCAAAGGCGGCTTGAAAGGTGCACTGCAGTTCAACAGCCACACACTACATCAGT GGCTCAAAGACAAGAACAAAGGAGAAATATATGATGCAGCCATTGACCTGTTTACACGTT CATGTGCTGGATACTGTGTAGCTACCTTCATTTTGGGAATTGGAGATCGTCACAATAGTA ACATCATGGTGAAAGACGATGGACAACTGTTTCATATAGATTTTGGACACTTTTTGGATC ACAAGAAGAAAAAATTTGGTTATAAACGAGAACGTGTGCCATTTGTTTTGACACAGGATT TCTTAATAGTGATTAGTAAAGGAGCCCAAGAATGCACAAAGACAAGAGAATTTGAGAGGT TTCAGGAGATGTGTTACAAGGCTTATCTAGCTATTCGACAGCATGCCAATCTCTTCATAA ATCTTTTCTCAATGATGCTTGGCTCTGGAATGCCAGAACTACAATCTTTTGATGACATTG CATACATTCGAAAGACCCTAGCCTTAGATAAAACTGAGCAAGAGGCTTTGGAGTATTTCA TGAAACAAATGAATGATGCACATCATGGTGGCTGGACAACAAAAATGGATTGGATCTTCC ACACAATTAAACAGCATGCATTGAACTGAAAAGATAACTGAGAAAATGAAAGCTCACTCT GGATTCCACACTGCACTGTTAATAACTCTCAGCAGGCAAAGACCGATTGCATAGGAATTG CACAATCCATGAACAGCATTAGAATTTACAGCAAGAACAGAAATAAAATACTATATAATT TAAATAATGTAAACGCAAACAGGGTTTGATAGCACTTAAACTAGTTCATTTCAAAATTAA GCTTTAGAATAATGCGCAATTTCATGTTATGCCTTAAGTCCAAAAAGGTAAACTTTGAAG ATTGTTTGTATCTTTTTTTAAAAAACAAAACAAAACAAAAATCCCCAAAATATATAGAAA TGATGGAGAAGGAAAAAGTGATGGTTTTTTTTGTCTTGCAAATGTTCTATGTTTTGAAAT GTGGACACAACAAAGGCTGTTATTGCATTAGGTGTAAGTAAACTGGAGTTTATGTTAAAT TACATTGATTGGAAAAGAATGAAAATTTCTTATTTTTCCATTGCTGTTCAATTTATAGTT TGAAGTGGGTTTTTGACTGCTTGTTTAATGAAGAAAAATGCTTGGGGTGGAAGGGACTCT TGAGATTTCACCAGAGACTTTTTCTTTTTAATAAATCAAACCTTTTGATGATTTGAGGTT TTATCTGCAGTTTTGGAAGCAGTCACAAATGAGACCTGTTATAAGGTGGTATTTTTTTTT TTCTTCTGGACAGTATTTAAAGGATCTTATTCTTATTTCCCAGGGAAATTCTGGGCTCCC ACAAAGTAAAAAAAAAAAAAAATCATAGAAAAAGAATGAGCAGGAATAGTTCTTATTCCA GAATTGTACAGTATTCACCTTAAGTTGATTTTTTTTCTCCTTCTGCAATTGAACTGAATA CATTTTTCATGCATGTTTTCCAGAAAATAGAAGTATTAATGTTATTAAAAAGATTATTTT TTTTATTAAAGGCTATTTATATTATAGAAACTATCATTAATATATATTCTTTATTTACAT GATCTGTCCCATAGTCATGCATTGTTTTGCACCCCAAATTTTTTATTGTTCATAGCAGCA TGGTCAGCTTTCTTCTTGATCTATAGATGAGGCTCAGGCACTATCCCATTTATACCAATA ACCAGTGTATAACTACTTAAGGAAAACATAAAAACTTCATCTTCTTTCCTTTTATTTCTT ATGTGAATCTCCCGTCTTCCATTCTCTTTTATAATTGAGAATGTCTCAATCATATGAAAT TAGTTACCAGAATTAACACAATTTAGACTATCTTCCTGATTCCTTAAACCCCTTTACTGA AGTATACTCATGAATAATACTTTAAAATATGGGGGAATAGAAACCATGAACTTTTTACCT TTTTAAACTATTTATCCATATCTCCAAAGTAGAACATTAAACCATTTTAAGATATGTCTC ATTCCCAAGTAGTCAGAGCTCACTCTCCAACTTTATTAAATACTATTTGAGCACAGGACA CATTCTTAAACATTTTGAAAAACATTAACCCAAGATGTAGAGGCTACTGCTAGTCGTCAT TCTAGAATCTGATATTTTACTCTGTATTTGAAATGAATGATTAATGTCCTAGGAAATTAG CTTTAGCAGATGTCCAGGTGCCACATCAAAAAAGTGCAATAATTATTGACAGTTTTTTAG ATTAGGCATATTATTGGAAAACAACTTTATAAAGAGTGAACATTGTATACTCTAGTAAAA CAGCATCACTTTAAAAATATTCATTTATGAAATCTGTTACCTATAGTTGAAGTCTTGAGT AGTGAACAAGGGACTCTAATACCAATACTCTTAATATCTGGCTATTTTAGATCCCTTAAA GGGCATAATTATTGGAAATTTAGGTATTTCACTAAAGCATGTATATAATATTGCCAACAA GAAAAGTAAATTTGAAGATTAAGGGAACTTACTTCTGCAAACTGTCTTGCGATAGTTAAG CAGAATTTAAACTCTGTTTTAAGCAGGAAACCAGAAAGATTATTTTGCAGTTGTAGAAGA TTTCATAACTTATTAAAACTTATTAACATTTTGTGTTGTTTAGATATAGGCAGTTGATAC ATACTAACATCCCAGCCTTTTCAATATCAGGGTTAAATTATAGGAAAACTCAGTAAAATG GTACAAATCTGAAAGTTTGATGGTAGAAACTGAAGATTTAACAGAGAACTGTGTTTTACC CGAGTGCCAAAAATGCTGTGAGCCTCCTTGCACAAAATTTATACCACTTTTGCATTTTTA TCTATCAGTCCAGATAGTTGTCTCCCCTCCTTCTCCCAGGACCTCTCCACCATTAAAATG CACAAACCACATGGCCGATTTCACCATTTACATTTATTTTCAAAAGTTACTACAACCAAA TTAATTCTATTAGAAGAAATGTAGACAAATTCTATAAAGACTATAGATTGTGACCTAAGA AAGAAATGAGGCAAAGAACCAAACATTGAATTAAATGCTACATGGGTGACTAAGATCTGT TTCAAGTCAGTGATAATATAGCCACTTCTGGGTACTTCAGTATCAGAGATCAGTTCTCGT GGTTTAGACAGTTCCTATCTATAGCTGACTATCCTTGTCCTTGAATATGGTGTAACTGAC TATTGGCTCTACAGTTTTATTGGGCCACTTAAGAAATATTTCCTTGAATAATTATTTTGA GAAAAAGTCTAAAAGTAATAAAAATAATTTTAAACACACTGTAGTAAGAAATGACTGTTG GAAAATTATGCTTTCACTTTCTACCATATTCTCAGCTATACAAAACCATTTATTTTGAAG ATTTTTAGACTACTGTTAATTTGAAATCTGTTACTCTTATTGTGGAATTTGTTTTTTTAA AAAAGATGTTTCTAATTGGATTTTTAAAAGAAGAATGGAATTTGGTTGCTATTTTACAAT AGAACCTAAGCTTTTTGTGGTTCTTAGTGTCCTATGTAAAACTTAGTGTCAAAGTAATCA ACTTTGAGATTTTCCCTTCTATTCTGCTTTATATTAAAAGCCCATTAGAAAATGGGAACC TGGTGAATATATAATGAATTGTAAAATATTTTAATGTGTAACTTTTTCAACTGTGAAACT GACTTGATTTTTTGATGAAAACAGCTGCTGATAAAGTATTTTGTGTAAAGTGTAGTTCTT ATTAATCAGGAAAATGATGACTTGATTAGACTGTATATGCCCTCTTGGATTTTATTTTAA ATGGATTGGTGACTTTCACATAGGTAAAACACAGTCCATCTGTATTCTTTTTTCCATCAA AAATCGAGTGATTTGGAATTATAAAAAAATTGTGAGCAGCCTATTTGAAAGGCATCATGG AAATTTCACAGCACAATAACACGGATTTGTTTTTTCTTAATGATGTAAATCCGTTTAATT CATACTTTGATCAATAGCCCATGCTTGCCAACTCTGAAGAAATTTAATTTCCAGCAGTAT TTTAAAGCTAGCCTGTTAACTTTTTCTGAATATTTAAAGTTCCTCTTTTTTCTATGTCTG CACAAACTGCAGACCTGGGCTGGACCCACATACTCAAGAGTCCACCTTAAGAAATTATTT TGATGTCCAAGACATCACTAAAATATTTAAGTTTAAAGATAATATGTGGTGTTAATAGAT TGTGGTGCTTTTACTATTTAAAGACAACTTTCATACTTCAGATGTTTTTGAGAAGAGGGG AATGTGAGGGGAGGGGGCAGAACAGGGAGGAGTTGTTTGAATGAATTACATTCTTTATAT CCATCCTGCTCATTTGGGGCATGTCTTTAAGAGAAGGCTGAAAGTTGTGAGAGTATATTG TATACCGTAAGAGAATCAACTCTTCATCATGGATGGGATTGTGAAGGCTGAACTATAAAA TTCAGCATTGACAGCATCCTCAATTAATAATTCTTGGTGACAGAATAATACAGCTGGGCT GTTTTTTAAAATATAAACAATACCATTTTTAATTATTACATTAAAAATTGTAAATATATC TATGTGCCATGGCCTGGGAAGCCTGCTTTCTTTTTTCATAAAAATTATTTTTACTGTATG AAAAGATCATGGGGTTTAGCTCAAAATATCTGTGGTCCTGATAAAATTGGATTGGTAACT CTACCTCAGAAGGAAAATGGGAAAAAAAAATAGATGAGTCACAATTCAATACTTCAAGCT CAGAAACTGTGCAGATCACTGAATTTTAGATTTATAAAGTCAGAGTTGGCATGCCTTGTT TTTAATGATATGGAAGACCTTAAGAAAAAAACTTGGCTGAAGTTTAATCGTTGGTCCAGC CATTTGAAAAAGGCAATAGTTTGAGGAGGTTCCCGAATTCGGCATTTGAAATTCATTTTG TTCTCTCTTCTTCATTATTAGTGCATTTGGTGTGTGTATACTTGCACACAATTCTGTTTG TGTACACACTGCTTGCTTAGCCCTAGTCAAGAGGCATCTTTTATAAAAGGTGTAAAGAAA TATCAAGGTTCTAAAATTCGGAAGAGTTTAGAATTTATTAGGAGTTTCCCAAGTTGGGAT GTTAGTCTTTAAATAAACTTCATGCACCTATTCCACTTAAGGTTTTGCACCTCCTTTTTA TTAGTGCAGTGCCATTTCTTCTGCTTGATTTTAGGTATGTTAATATTCCAGCCTTGCTAG TTAGCATAAAGTGACAGGTGTGAGCCATGAGGAAATTTTCTGACTTAATTTGTACACAAC TACATATAAGAGTTTTAGTGGAGGAAAAAAATTAGTCCCTTGTGCGTATACAGTAGTTAG GTAAATGATTTTTCTACCAACAGTATACTCCATTCCTCATGTAGGTAAGTACAGAAAAGG TTTTTAAATGTATTTTTTTAGCCAGTTAAAGTCTATGAATCTATCTGCAACCTTATTTAA TCTGTCACTATAATAATTTTGTGGTTATGCTAAGAACCATGTATACTTTTAGGTATTCTT ATTTTTGTCAATTTTTCTAGGTTGGCAAGGAGGCAGAAAACCTTCATTGTTTCATATTAA AATATAATTAGACTAAACTTAATTCTAGTATGAATTTCCAAAATCATTATCTATTTATTT CATTTTTATTTAATTTTGTTTTTATTTCATTTTTAAAAGTCCCTTGTTCAATTTAACTTA TGTTCCTAAGAGAGGTTGGAGAACTTGGCCTTCATCTGATTTCAAAAATGTTTTGAGTTT CAAATGAAGTTAATGGTTTCAGTGTGATTCAGTCCTCAGACCTAATTGGGTTGAATAAAA TCTAAAAGAATATACCCTTTTGGAGCATAACATTTTAATACCTTGGGGAATGTGGCACTA CCAAAAGAAGACTACTAACACGTCAGATGTTCACCTGGAAGCTTTATCAAGAAATTCGAA CCACCCTTTTGGCCCCATTAATTGTAGCAAGTTTATTTCTCTATATTTTGTCATTCAGTG AATTGAAGTCCTGTGGTATACTGCATTCATTAGAAGAAAAACGTTTTTAATGTCCTTTTA ATGATGGCCCAGAAAGCATTTGACACAGCAAGATGCATGTGTTACTATATTGAGAATATA GAATAATAACAGTATCACTAAATTTAAGACCTCTTCCCAGTCTTGCTGTTCCTAGCAAGA AGTTTGGCCTGTGACTGCACTTACTGTTTATGCTCATCAGAAACTGTCAATGTCTGCTTT TCTTTAACTCTGCAGTCTGTAACATCACGCTGTTTATTAAAAAAAAAAA |
Protein Sequence | >5290 : length: 1068 MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLITIKHELFKEARKYPLHQ LLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFA IGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPNVESSPELPKH IYNKLDKGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLK LCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLMLMAKESLYSQLPMD CFTMPSYSRRISTATPYMNGETSTKSLWVINSALRIKILCATYVNVNIRDIDKIYVRTGI YHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHC PLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWF SSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPL SEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAME LLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTN QRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILK QEKKDETQKVQMKFLVEQMRRPDFMDALQGFLSPLNPAHQLGNLRLEECRIMSSAKRPLW LNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLS IGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRS CAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDF LIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIA YIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN |